Skip to search formSkip to main contentSkip to account menu

GW 678248

Known as: GW-678248, GW678248 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BACKGROUND Although a number of agents can achieve high response in acquired immunodeficiency syndrome (AIDS) patients, safer and… 
2016
2016
Through a structure‐based molecular hybridization and bioisosterism approach, a series of novel 2‐(pyridin‐3‐yloxy)acetamide… 
Review
2016
Review
2016
Developing non-nucleoside HIV-1 reverse transcriptase inhibitors (NNRTIs) with improved drug resistance profiles is still a great… 
2010
2010
GW695634 is the prodrug of GW678248, a novel non-nucleoside reverse transcriptase inhibitor with potent antiviral activity… 
2010
2010
BackgroundCurrent antiretroviral therapy against human immunodeficiency virus (HIV-1) reduces viral load and thereby prevents… 
Highly Cited
2006
Highly Cited
2006
Despite the progress of the past two decades, there is still considerable need for safe, efficacious drugs that target human… 
Highly Cited
2005
Highly Cited
2005
ABSTRACT The compound GW678248 is a novel benzophenone nonnucleoside reverse transcriptase inhibitor (NNRTI). Preclinical… 
2005
2005
ABSTRACT GW678248, a novel nonnucleoside reverse transcriptase inhibitor, has been evaluated for anti-human immunodeficiency…